All BHMG Oncology | Oncology | Baptist Health South Florida

Menu

Skip to main content

All BHMG Oncology

Submissions from 2025 2025

MR-Guided Single-Fraction Stereotactic Ablative Body Radiation Therapy for Extracranial Metastases: The Miami Cancer Institute Experience, Michael Chuong

NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy, Michael Chuong

Gabapentinoids confer survival benefit in human glioblastoma, Matthew Hall and Yazmin Odia

Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview, Rupesh Kotecha and Alonso La Rosa

A pilot survey into the landscape of neuro-oncology care in the community, Rupesh Kotecha and Yazmin Odia

Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825, Minesh Mehta

Submissions from 2024 2024

An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice, Eyub Akdemir, Yazmin Odia, Matthew Hall, Minesh Mehta, and Rupesh Kotecha

Comparative evaluation of the diagnostic and prognostic performance of CNSide™ versus standard cytology for leptomeningeal disease, Haley Appel, Muni Rubens, Mukesh Roy, Rupesh Kotecha, Matthew Hall, Minesh Mehta, Zhijian Chen, Manmeet Ahluwalia, and Yazmin Odia

A narrative review of minimally invasive pancreatic surgery: from pipedreams to pancreatoduodenectomies, Domenech Asbun, Nuria Lluis Vinas, Ramon Jimenez, and Horacio Asbun

A cross sectional survey on burnout and career satisfaction in surgeons: a joint work from the SAGES quality, outcomes, and safety and reimaging the practice of surgery burnout task forces, Horacio Asbun

Autogenic splenic implantation versus splenectomy in patients undergoing distal pancreatectomy for benign or low-grade malignant lesions of the distal pancreas: study protocol for a multicentre, open-label, randomized controlled trial (RESTORE), Horacio Asbun

International survey on opinions and use of robot-assisted and laparoscopic minimally invasive pancreatic surgery: 5-year follow up, Horacio Asbun

Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial, Horacio Asbun

Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial, Horacio Asbun

Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial, Horacio Asbun

REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer: management algorithm, unanswered questions, and future perspectives, Horacio Asbun

REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer, Horacio Asbun

Standardizing definitions and terminology of left-sided pancreatic resections through an international Delphi consensus, Horacio Asbun

The Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery (EGUMIPS), Horacio Asbun

The joy of surgery: how gender influences surgeons' experiences, Horacio Asbun

The joy of surgery: how surgeons experience joy, time, and support, Horacio Asbun

Advancing minimally invasive hepato-pancreato-biliary surgery: barriers to adoption and equitable access, Horacio Asbun and Domenech Asbun

Advancing minimally invasive hepato-pancreato-biliary surgery: barriers to adoption and equitable access, Horacio Asbun and Domenech Asbun

Advancing minimally invasive hepato-pancreato-biliary surgery: ensuring safety with implementation, Horacio Asbun and Domenech Asbun

An Overview of the Therapeutic Strategies for Neoplastic Meningitis due to Breast Cancer: When and Why?, Mainak Bardhan, Ahmad Ozair, Reshma Mahtani, Yazmin Odia, and Manmeet Ahluwalia

Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Andrew Barsky, Jerry George, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong

Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Andrew Barsky, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors, Bruno Bastos

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors, Bruno Bastos

Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436), Bruno Bastos

Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies, Bruno Bastos

In Reply to Cellini and Fiore, Michael Chuong

Quality and Safety Considerations for Adaptive Radiation Therapy: An ASTRO White Paper: ASTRO ART Safety White Paper, Michael Chuong

Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas, Michael Chuong

TCF4 as a potential prognostic biomarker and an anticancer target in gastric cancer, Michael Chuong

TCF4 as a potential prognostic biomarker and an anticancer target in gastric cancer, Michael Chuong

The Dust Has Finally Settled, but Is the View Any Clearer?, Michael Chuong

The Dust Has Finally Settled, but Is the View Any Clearer?, Michael Chuong

Upping the Ante in the Treatment of Gastrointestinal Cancer, Michael Chuong

Quality assurance of an established online adaptive radiotherapy program: patch and software upgrade, Michael Chuong, Rupesh Kotecha, Yonatan Weiss, Minesh Mehta, Alonso Gutierrez, and Kathryn Mittauer

SBRT vs. Conventional Radiotherapy for Painful Spinal Metastases: A Comparative Analysis of Randomized Trials and Practical Considerations, Omer Gal, Robert Rothrock, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha

Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy for Painful Spinal Metastases: A Comparative Analysis of Randomized Trials and Practical Considerations, Omer Gal, Robert Rothrock, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha

Impact of TP53, RB1, and PTEN Mutations on Overall Survival in Metastatic Prostate Cancer: A Multi-center Study Via the Guardian Research Network., Mohammad Ganiyani, Pushan Prabhakar, Atulya Khosla, Shreyas Bellur, Arjun Avudaiappan, Bruno Bastos, and Rohan Garje

Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies, Rohan Garje and Bruno Bastos

Corrigendum: A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry, Jerry George, Ranjini Tolakanahalli, Santiago Aguirre, Taehyung Kim, and Vivek Mishra

Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Jerry George, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong

Corrigendum: A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry, Siju George, Ranjini Tolakanahalli, Santiago Aguirre, and Vivek Mishra

A Review of Immunotherapy for Head and Neck Cancer, Jeffrey Goetz, Noah Kalman, and Alessandro Villa

Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma, Lauren Gonzalez, Muni Rubens, Sreenija Yarlagadda, Guilherme Rabinowits, and Noah Kalman

Proton Pencil Beam Scanning Facilitates the Safe Treatment of Extended Radiation Targets for Hodgkin Lymphoma: A Report from the Proton Collaborative Group Registry, Matthew Hall

Weight Loss, Pathological Changes, and Inflammatory Effects from a Short-Term Ketogenic Diet in Overweight and Obese Men with Untreated Prostate Cancer on Active Surveillance, Adeel Kaiser

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group, Noah Kalman and Robert Press

In Regard to Youssef et al, Noah Kalman and Sreenija Yarlagadda

Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance, Noah Kalman and Sreenija Yarlagadda

Establishing Updated Safety Standards for Independent (99)(m)Tc-MAA SPECT/CT Treatment Planning in Radioembolization, Taehyung Kim, Ripal Gandhi, Ranjini Tolakanahalli, Raul Herrera, Michael Chuong, Alonso Gutierrez, and Diane Alvarez

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial, Rupesh Kotecha

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial, Rupesh Kotecha

Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma, Rupesh Kotecha

Repeat Single-Session Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations: A Systematic Review, Meta-Analysis, and International Stereotactic Radiosurgery Society Practice Guidelines, Rupesh Kotecha

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines, Rupesh Kotecha

Stereotactic Radiosurgery for Intermediate (III) or High (IV-V) Spetzler-Martin Grade Arteriovenous Malformations: International Stereotactic Radiosurgery Society Practice Guideline, Rupesh Kotecha

Stereotactic Radiosurgery for Intracranial Cavernous Malformations: International Stereotactic Radiosurgery Society, Systematic Review, Meta-Analysis, and Practice Guidelines, Rupesh Kotecha

Early experience and perioperative risk of GammaTile for upfront brain metastases: Report from a prospective multicenter study, Rupesh Kotecha and Manmeet Ahluwalia

How proton therapy fits into the management of adult intracranial tumors, Rupesh Kotecha, Alonso La Rosa De Los Rios, and Minesh Mehta

In Regard to Trifiletti et al, Rupesh Kotecha and Minesh Mehta

Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined Era, Rupesh Kotecha and Minesh Mehta

Stereotactic Body Radiotherapy for liver metastases: Systematic review and meta-analysis with International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines, Rupesh Kotecha and Zhenwei Zhang

Incidence and outcomes of postoperative fluid collections after minimally invasive distal pancreatectomy without placement of surgical drain. A prospective observational cohort study, Filipe Kunzler, Domenech Asbun, Ramon Jimenez, and Horacio Asbun

Incidence and outcomes of postoperative fluid collections after minimally invasive distal pancreatectomy without placement of surgical drain. A prospective observational cohort study, Filipe Kunzler, Domenech Asbun, Ramon Jimenez, and Horacio Asbun

Emerging potential of tumor treating fields as a treatment modality for pancreatic cancer: a narrative review of therapeutic evolution, Tugce Kutuk, Adeel Kaiser, and Michael Chuong

Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso LaRosa, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli

Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso La Rosa De Los Rios, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli

Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso La Rosa De Los Rios, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli

Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy, Tugce Kutuk, Alessandro Villa, and Noah Kalman

Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy, Tugce Kutuk, Alessandro Villa, Noah Kalman, and Adeel Kaiser

Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis, Tugce Kutuk, Yanjia Zhang, Eyub Akdemir, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Alonso La Rosa De Los Rios, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Yazmin Odia, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Robert Press

Initial feasibility cohort of temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade intracranial malignancies, Alonso LaRosa, Zachary Fellows, Andrew Wroe, Len Coutinho, Eduardo Pons, Nicole McAllister, Ranjini Tolakanahalli, Tugce Kutuk, Matthew Hall, Robert Press, Michael McDermott, Yazmin Odia, Manmeet Ahluwalia, Minesh Mehta, Alonso Gutierrez, and Rupesh Kotecha

Accelerated Hypofractionated Magnetic Resonance Guided Adaptive Radiation Therapy for Ultracentral Lung Tumors, Alonso La Rosa de los Rios, Kathryn Mittauer, Nema Bassiri-Gharb, Amy Rzepczynski, Michael Chuong, Sreenija Yarlagadda, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha

Clinical application of an institutional fractionated stereotactic radiosurgery (FSRS) program for brain metastases delivered with MRIdian(Ⓡ) BrainTx™, Alonso La Rosa De Los Rios, Kathryn Mittauer, D Jay Wieczorek, Cecilia Lee, Amy Rzepczynski, Michael Chuong, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha

Intraductal papillary neoplasms of the bile ducts: a comparative study of a rare disease in Europe and Nagoya, Japan, Nuria Lluis Vinas and Horacio Asbun

Racial and ethnic disparities in prostate cancer screening following the 2018 US Preventive Services Task Force recommendation statement, Murugesan Manoharan and Jorge Caso

A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults, Minesh Mehta

Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825, Minesh Mehta

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial, Minesh Mehta

DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology, Minesh Mehta

DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology, Minesh Mehta

Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001, Minesh Mehta

Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001, Minesh Mehta

Evaluating the sensitivity of EQ-5D-5L in patients with brain metastases: a secondary analysis of NRG CC001, Minesh Mehta

Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614, Minesh Mehta

Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice, Minesh Mehta

In Reply to Halperin, Minesh Mehta

NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed GBM, Minesh Mehta

NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma, Minesh Mehta

Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based Approach, Minesh Mehta

Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012 to 2021) From the National Association for Proton Therapy, Minesh Mehta

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas, Minesh Mehta

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas, Minesh Mehta

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta